Tursi A, Mocci G, Allegretta L, Aragona G, et al. Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study. Inflamm Bowel Dis 2023;29:376-383.
PMID: 35579320